Objectives Ulcerative colitis (UC) is associated with an increased risk of colorectal cancer (CRC). Few studies have looked at long-term outcomes of endoscopically visible adenomatous lesions removed by endoscopic resection in these patients. We aimed to assess the risk of developing CRC in UC patients with adenomatous lesions that develop within the segment of colitis compared to the remainder of an ulcerative colitis cohort. Methods We identified patients with a confirmed histological diagnosis of UC from 1991 to 2004 and noted outcomes till June 2011. The Kaplan-Meier method was used to estimate cumulative probability of subsequent CRC. Factors associated with risk of CRC were assessed in a Cox proportional hazards model. Results Twenty-nine of 301 patients with UC had adenomatous lesions noted within the segment of colitis. The crude incidence rate of developing colon cancer in patients with UC was 2.45 (95 % CI 1.06-4.83) per 1000 PYD and in those with UC and polypoid adenomas within the extent of inflammation was 11.07 (95 % CI 3.59-25.83) per 1000 PYD. Adjusted hazards ratio of developing CRC on follow-up in UC patients with polypoid dysplastic adenomatous lesions within the extent of inflammation was 4.0 (95 % CI 1.3-12.4). Conclusions The risk of developing CRC is significantly higher in UC patients with polypoid adenomatous lesions, within the extent of inflammation, despite endoscopic resection. Patients and physicians should take the increased risk into consideration during follow-up of these patients.
Introduction
Patients with long-standing, extensive ulcerative colitis (UC) have an increased risk of developing colorectal carcinoma [1] . Since the first description by Blackstone et al. [2] , the finding of a raised dysplastic lesion was considered an ominous finding. Of 112 patients with UC in this study, 12 raised lesions with dysplasia were found and 7 (58 %) of them had invasive cancer in the colectomy specimen. The term dysplasia-associated lesion/mass (DALM) was coined to describe these lesions. Subsequently, Bernstein et al. [3] in a systematic review of ten prospective studies found that 17 (43 %) of 40 cases with DALM's had associated colon cancer.
The treatment of patients with UC and DALM's has remained controversial. Blackstone et al. [2] suggested that dysplasia associated with a DALM, especially a polypoid mass, was an indication for colectomy in view of the increased likelihood of cancer. Several subsequent studies seem to support this argument [4] [5] [6] [7] . The criticism leveled at these studies was that the lesions detected were fairly advanced, and despite endoscopic biopsies not revealing a cancer, subsequent surgery and histological examination of the specimens revealed the underlying cancer. More recently, a distinction has been made between sporadic adenomas which have been described as discrete well-defined, sessile or pedunculated polyps resembling adenomas in patients without inflammatory bowel disease and other (non-adenoma-like) DALM's which are broad-based sessile, irregular, ulcerating or stricturing lesions [8, 9] . Other studies have classed only those polyps outside the extent of histological inflammation as sporadic adenomas further adding to the confusion in terminology of these lesions [10] . The recent SCENIC guidelines suggests using the standard Paris classification for colorectal lesions along with additional descriptors of whether the lesions was within the colitic segment, circumscribed endoscopic resectability and associated ulceration [11] . A systematic review which included ten studies, with 376 IBD patients with resected polypoid dysplasia followed up for a mean of 54 months, reported an pooled incidence for dysplasia and CRC of 65 and 5.3 cases per 1000 patient years, respectively [12] .
On the basis of these studies, it has been suggested that patients with endoscopically resectable raised dysplastic lesions associated with UC should not have colectomy. The recommendation of the SCENIC panel based on nine studies reviewed (all retrospective and single arm) on the endoscopic management of polypoid dysplastic lesions during the video-endoscope era was: endoscopic resection with continued surveillance [11] . One of the major criticisms of these studies was that they were mainly single arm (no comparator) and did not take into account other risk factors for cancer. Risk of cancer in patients with UC is dependent on disease duration [1] and also on age [13] , sex [14] , and extent of disease [1, 13] . Risks of cancer in patients with UC are therefore best expressed on the basis of duration of disease and adjusted for risk factors. A Dutch pathology database (PALGA) study showed that the adjusted risk of developing advanced neoplasia on follow-up for patients with IBD and adenomas compared to IBD patients without adenomas was 2.8-fold higher (95 % CI 1.0-8.2) underscoring the need for intensive surveillance following endoscopic resection [15] .
Aims of the Study
The aim of this study was to compare the risk of subsequently developing colorectal cancer in patients with UC and endoscopically resectable polypoid dysplastic lesions within the extent of histological inflammation compared to the remainder of the UC cohort.
Methods

Subjects
All adult patients with a histological diagnosis of ulcerative colitis made between 1991 and 2004 were identified from the histopathology database at St George's Hospital, London, a larger University teaching hospital. Patients were included in the study only if they had undergone colonoscopy with segmental biopsies in this institution. Standard protocol was performed taking biopsies from all segments of the colon. Patients who were not under follow-up primarily at St George's Hospital and referred with a diagnosis of colon cancer were excluded from the study. All data on endoscopy and histology were obtained from the electronic patients records of St George's Hospital. If data were incomplete or unclear in the electronic records, patient charts were traced through medical records and scrutinized. For this study, duration of follow-up was defined as the time from which the histological diagnosis of UC was first confirmed to the time when the last colonoscopy with segmental biopsies was performed in this hospital, or to the time when total or subtotal colectomy was done. Follow-up data noted on the electronic patient records till June 2011 were recorded (at least 7 years after the last inclusion colonoscopy). Histopathology and endoscopy reports were reviewed to detect whether patients developed further adenomatous lesions with low-grade dysplasia, high-grade dysplasia, or CRC during follow-up.
Since this was a retrospective study, we did not attempt to distinguish between ALM's and DALM's. Patients with raised endoscopically resectable dysplastic polypoid lesions seen within the extent of colonic inflammation with no evidence of flat dysplasia adjacent or remote to the polypoid lesion were included in the UC with adenomatous polyp arm. All other patients with UC were placed in the comparison cohort. The endoscopy report was used to determine the location and size of the polyp and whether the polyp was resected endoscopically. Standard snare resection techniques were used for stalked polyps and endoscopic mucosal resection after submucosal injection of saline, or a hypertonic solution was used for sessile and non-polypoid lesions based on the endoscopist's choice. Completeness of resection was based on endoscopist's impression where available.
Dysplasia was classified as either low-grade or highgrade, according to standard criteria and definitions based on Ridell et al. [16] . Histopathology reports were based on routine reporting by a GI histopathologists and a discussion of the pathology at the weekly multi-disciplinary team meeting where the pathology would be reviewed by a second GI histopathologist.
Statistical Analysis
Statistical analysis was performed using SPSS version 21 (IBM corporation, USA) statistical package. All baseline values were recorded as mean ± standard deviation (SD) or percentages. Crude incidence rates (number of cases during the period of observation divided by the total person-time of observation) for each group were calculated and expressed as number of cases per 1000 persons years of disease duration (PYD).
The Kaplan-Meier method was used to estimate cumulative probability (1 minus survival free) of subsequent CRC. Comparisons between groups were made using Breslow log-rank tests. The Cox proportional hazards regression model was used to assess the associations of clinical variables on development of CRC. The following variables were assessed in these models: (1) the presence of a endoscopically resectable polyp versus none detected; (2) disease extent (extensive versus other); (3) age at diagnosis, and (4) gender (male or female). Results are reported as hazard ratios (HR) with 95 % confidence intervals (95 % CI).
Results
Of the 751 patients with a histological diagnosis of UC made between 1991 and 2004, 397 patients had at least one colonoscopy with serial mucosal biopsies during this period. The remainder did not fulfill the inclusion criteria either because they had only a rigid or flexible sigmoidoscopy or had an incomplete colonoscopy either because they did not tolerate the procedure or had poor bowel preparation. A further 96 did not have any further followup at St George's hospital till June 2011 and were excluded. Of the 301 patients included, 29 had endoscopically detected polypoid dysplastic lesions within the extent of colonic inflammation at some point. A further five patients had adenomas outside the extent of UC and were included in the comparison cohort of all other UC patients. Table 1 outlines the patient characteristics of these two groups, and Fig. 1 provides a flowchart showing the outcomes at end of follow-up. Of the 29 patients with polypoid adenomatous lesions within the extent of colitis, 27 had their lesions endoscopically resected. Table 2 outlines the salient characteristics of the polyps detected in this group. One patient had a sessile broad-based polyp in the rectum with lowgrade dysplasia on endoscopic biopsies and refused any endoscopic or surgical procedures and on follow-up colonoscopy 27 months later had no progression of the lesion on repeat endoscopic biopsies. Another patient with a sessile polypoid lesion in the descending colon with lowgrade dysplasia on endoscopic biopsies opted to have a colectomy, and the specimen revealed no evidence of any invasive cancer or high-grade dysplasia. Five patients developed invasive adenocarcinoma in the same segment between 14 and 48 months after the initial endoscopic resection. Ten patients had recurrent polypoid dysplastic lesions noted in a median follow-up of 49 months (range 12-108 months) after the initial endoscopic resection, which were also endoscopically treated. Five of these 29 patients had high-grade dysplasia on their initial endoscopic resection specimen, of which two subsequently developed carcinoma on follow-up.
The comparison cohort consisted of 272 patients with UC with no polypoid dysplastic lesions within the extent of the colitis. There were five adenocarcinomas detected, of which one had prior high-grade dysplasia detected only by random colonoscopic biopsies. Eight patients had lowgrade dysplastic lesions (not visible endoscopically) detected only on random colonoscopic biopsies, none of which had progressed till the end of follow-up.
The crude incidence rate of developing colon cancer in patients with UC was 2.45 (95 % CI 1.06-4.83) per 1000 PYD and in those with UC and polypoid adenomas within the extent of inflammation was 11.07 (95 % CI 3.59-25.83) per 1000 PYD. Figure 2 shows the Kaplan-Meier curve of the cumulative risk of developing CRC comparing patients with a polypoid dysplastic lesion within the extent of inflammation to those without (log-rank test p = 0.007). Table 3 shows the Cox proportional hazards analysis of the factors associated with the development of CRC. The presence of a polypoid dysplastic lesion within the extent of colitis was associated with fourfold risk in the risk if subsequent CRC and this risk were maintained even after multivariate analysis adjusting for extent, age of diagnosis, and gender.
Discussion
Patients with ulcerative colitis with an endoscopically resectable dysplastic polypoid lesions, within the extent of colonic inflammation, have nearly a fourfold risk of subsequently developing cancer compared to a cohort of UC patients not having similar polypoid dysplastic lesions. While five patients (17 %) subsequently developed a carcinoma, of the remaining 24 patients, ten patients (42 %) had recurrent polypoid dysplastic lesions detected on follow-up which is similar to the findings of Odze et al. [17] . We believe that taking the total duration of disease and not just the follow-up period post-polypectomy or excision of lesion should be taken into account when determining risk. We also adjusted the risk estimate for age, sex, and extent of disease. This reflects a more accurate perception of the risk of colorectal cancer in these patients. Our results are therefore similar to that by the Mayo group who found that the 5-year cumulative risk of subsequent colonic neoplasia after endoscopic resection in both those with sporadic adenomas and those with adenoma-like masses to be 68.5 and 70.6 %, respectively [10] . A Dutch pathology database study showed that the adjusted risk of developing advanced Dig Dis Sci (2016) 61:3031-3036 3033 neoplasia on follow-up for patients with IBD and adenomas compared to IBD patients without adenomas was 2.8-fold higher (95 % CI 1.0-8.2) which is also reflected in the results of the present study [15] . A systematic review which included ten studies, with 376 IBD patients with resected polypoid dysplasia followed up for a mean of 54 months, reported an pooled incidence for dysplasia and CRC of 65 and 5.3 cases per 1000 patient years, respectively [12] . As with all retrospective analyses, there are several limitations to our study. We have not been able to match for confounding factors such as family history of colon cancer [18] and medication usage which could affect the risk [19] . A study from the Mayo clinic, however, did not find any association between 5ASA use and subsequent development of colorectal neoplasia after endoscopic resection [10] . The endoscopic procedures were performed by different endoscopists, which is a potential factor in influencing the completeness of resection and subsequent risk of recurrence although all were appropriately accredited. Additionally, it was not always possible to determine completeness of excision based on retrospective evaluation Age at diagnosis in years (±SD)
49 (17) 38 (20) Duration of colitis in years (±SD)
16 (10) 12 (11) Male (%) 18 (62) 144 (53) No. with extensive colitis (%)
17 (59) 144 (53) Number of random biopsies: median 12 8 Fig. 1 Flowchart showing the final outcomes of patients included in this study at the end of follow-up of endoscopy reports as this was not always explicitly commented on in reports. Diathermy artefacts could also preclude the histopathologists from commenting on completeness of excision especially when small polyps were resected with a hot biopsy forceps (as was the practice at the time of the study) or when larger polyps were resected piecemeal. However, all procedures were performed by accredited endoscopists and reflect real-world practice in a standard National Health Service setting. Another source of bias could have arisen because we interpreted the histology on the basis of the prior routine histology report and discussion of the histology at a multidisciplinary meeting. Due to limited storage capacity, slides over 10 years old are discarded by our histopathology department precluding retrospective re-examination. Since all the original sections could not be reviewed, the prior routine reports were used throughout. We believe that this is an entirely reasonable approach as the clinical treatment of these patients was based on the original reports and reflects routine clinical practice. Various methods have been described using endoscopic and histopathological techniques including immunohistochemistry to characterize these lesions as sporadic adenomas and adenoma-like masses with no current consensus on the reliability of these various criteria. We have avoided recategorizing these lesions retrospectively, mainly because we feel that from a clinical perspective, these lesions form part of the same spectrum, analogous to that seen in sporadic adenomas. Lesions which are non-resectable are likely to be bigger and harbor cancer, while endoscopically resectable lesions are likely to be smaller and benign [20] . None of our patients had cancer noted in the initial endoscopic resection specimen. Additionally, a study from the Mayo clinic showed that the risk of subsequent neoplasia after endoscopic reaction was similar in UC patients classed as having sporadic adenomas as well as those with adenoma-like masses [10] .
The median number of biopsy specimens in this study was 8, which is very similar to practice elsewhere in the UK. Self-reported number of biopsies in a survey of UK gastroenterologist revealed that 57 % take fewer than ten biopsies per patient [21] . The St Mark's group also reported a median number of eight biopsies in their surveillance program [20] . Our figures are therefore High-grade dysplasia 5 (17) Fig. 2 Kaplan-Meier curve comparing the development of CRC between UC patients with polypoid dysplastic lesions within the extent of inflammation and the reference UC population representative of UK clinical practice and can be generalizable to most clinical practices. This could have led to lower identification of dysplasia, but conversely, many studies have shown an extremely low yield of dysplasia from non-targeted biopsies compared to targeted biopsies suggesting that the incremental benefit from multiple nontargeted biopsies is small [11, 22] . As this study was a single-center retrospective study which depended on patient follow-up in a single institution and while all patients underwent colonoscopy with biopsies, this was not done in a protocolized fashion as evidenced by the low median number of random biopsies taken. These factors, however, are likely to bias the study toward under detection of the outcomes of interest. Polypectomy has been suggested to be adequate therapy for UC patients with adenomatous polyps which endoscopically or histologically resemble sporadic adenomas. This study demonstrates that there is an increased risk of developing colorectal cancer in this patient group with dysplastic polyps within the extent of inflammation compared to the rest of the general UC population. Patients and physicians need to be aware of this increased risk before deciding on treatment options. Complete endoscopic removal and subsequent strict endoscopic surveillance protocols are therefore needed after endoscopic resection of adenomatous lesions in patients with ulcerative colitis. Since this is a single-center retrospective study with small numbers, further prospective multicenter studies are required, taking into account risk factors such as family history of colorectal neoplasia, the presence of primary sclerosing cholangitis, use of thiopurine and 5-aminosalicylate drugs, and duration and extent of UC to validate these observations. Author Contributions VS, RP, and CF contributed to study concept and design. VS, SC, FE, and AB collected the data. VS performed statistical analysis, wrote the first draft of the paper, and edited the manuscript. All authors approved the final version.
